A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
The field of cancer immunotherapy and immunology is rapidly reshaping modern oncology, yet the translational gap between mechanistic discoveries and durable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results